The Product Eyecheck System is a modular SaaS platform that effectively enables sharing of clinical imaging, referrals, and other clinical correspondence instantly and securely between healthcare professionals, such as optometrists, eye doctors, and hospitals. By digitizing the patient journey we enable quicker treatments and fewer patient queues as we can process more patients with uncomplicated diagnoses more effectively. The Problem The prevalence of the most common retinal diseases, age-related macular degeneration (AMD) and diabetic retinopathy (DR), is rising in industrialized countries. In addition to demographic changes, this trend is also partly driven by growing numbers of patients with diabetes. This is increasing the workload in hospital ophthalmic units, and public ophthalmologists leading to waiting times of up to 12 months in Norway. This in turn increases the risk for serious eye damage in the general population at risk. The Solution Eyecheck System is a modular SaaS platform that shares clinical imaging, referrals, and other clinical correspondence securely and instantly between healthcare professionals. This in turn enables decentralized controls and diagnosis of patients even in rural areas with sub-optimal eye specialist coverage. Decentralized controls and screenings are made possible due to the vast amount of geographically spread retina imaging devices in over 600 optometrist locations throughout Norway alone. In addition to that, there is a wide-ranging discrepancy of competence levels across the profession of optometrists, where such a service would benefit both the patients and the optometrists. The reason why We are passionate about Eyecare and want to avoid blindness and other serious eye complications in Europe by digitizing the patient journey and creating a modern, more sustainable way to help patients get better. Our founder is an ophthalmologist (eye doctor) in Akershus and embarked on this journey due to his own experience when meeting patients that waited unnecessarily long on their appointment and ultimately an uncomplicated diagnosis.

Our SaaS platform gathers data about employees through our browser extension, phishing simulation, test assessments, and integrations with password management solutions, and automatically generates actions for employees to perform based on their individual weaknesses. CYBR will be the new standard for managing and mitigating employee risk, all through one seamless platform, whilst offering Cyber Insurance, where the premium is calculated based on the company risk score. We are headquartered in Oslo, Norway, but 40% of the tech team is employed remotely.

We are a family business located on the island of Gossen in Northwestern Norway. Our goal is to reinvigorate Norway’s centuries old production of sea salt.We are a Norwegian producer of all natural sea salts. Our clean mineral-rich sea and dedication to quality gives our salt its great character, taste and personality. Our Flake Salt HAVSNØ [Snow of the SEA] is available in stores in Norway, Germany and USA and can be tasted in some of the worlds best restaurants.

Spiff is your personal assistant for saving and investing money. For yourself and your loved ones. We believe in equal opportunities for everyone. Unfortunately, this is not how the world works today. We want to change this by providing a service that makes planning, saving and investing easier and more accessible than ever before. We believe that women hold the key to a better world, so that is where we start our work for more equality. Spiff is a social, meaningful and rewarding savings-app.      Spiff was born as a result of two passionate feminist entrepreneurs seeking to capitalize on their skills and experience to make a difference. Aware of inequalities across gender, culture, race and other loci, Spiff aspires to increase the accessibility of saving and investing money and to empower anyone to be financially independent.

Aether is a Norwegian startup based in Oslo, founded by a team of developers with deep expertise in maritime vessels and sensor data. We conduct onboard testing in Tromsø, and conduct our commercial activities in Ålesund and Oslo. We are building a SaaS platform for ships that maintains safe and accurate navigation during GPS jamming and spoofing, helping vessels operate with confidence when traditional positioning systems fail.

Mimir automates customer service for e-commerce using AI. We resolve up to 90% of support inquiries. Not by deflecting customers, but by actually helping them. We've been heads down building and making Mimir the best AI agent for customer support the last 20 months. Now we're scaling fast, breaking into several new markets, and we need all hands on deck.

About Bill Kill AS Bill Kill is a Norwegian fintech company regulated by the financial authorities in both Norway and Sweden. Since launching in 2020, we have grown rapidly with a simple but powerful idea: letting people pay fixed expenses using a credit card and earn rewards as they go. With Bill Kill, everyday payments can unlock more value. Depending on the credit card, users can earn access to business class flights, upgraded hotel rooms, airport lounges, two-for-one travel offers, complimentary dinners, and other benefits. After strong growth in Norway, we have now launched in Sweden and are looking for a structured and hands-on Office Manager to support our local operations.

Perlo is spearheading the AI for Project Management revolution! Project managers in property development use Perlo to easily capture and track their project tasks while our risk prediction assistant helps them to actively prevent cost overruns so easily encountered in the world of building. With our personal industry background and the market's lack of any fitting digital project management solution for our industry, we were able to create a solution finally fitting for property developers - the people in charge of ensuring that our world develops.

XperiTech is a technology company that offers digital solutions for service providers in the travel industry. Our focus is on seamless customer travel and profiling of local experiences and tourism. Our slogan is "Better technology for better travel experiences". Today, we run the two brands Elveguiden and Campio, and we are an established startup with financial security. Our brands: Elveguiden - Norway's largest provider of salmon fishing. In addition supplier of systems for river management.Campio - Norway's largest portal for camping in Norway, and provider of digital solutions for the industry

We improve the way the shipping industry works and communicates. The whole industry is currently bogged down with unstructured emails and ship data.We have built a great ship database, and have a growing and happy customer base just from this. But we are not done. We are building communication tools on top of this, massively increasing the number of users we can help out!

Apotek 1 er Norges største apotekkjede og vi er i stadig vekst. Hos oss jobber ca. 3500 dedikerte medarbeidere, og vi er også landets største farmasøytiske arbeidsgiver. Vi har en stolt kultur med klare ambisjoner om alltid å leve opp til vårt slagord 'Vår kunnskap - din trygghet' i våre kundemøter. Kompetanse og kvalitet er kjernen for vår virksomhet, og derfor er faglig og personlig videreutvikling av våre medarbeidere helt sentralt i kjeden. I Apotek 1 er vi opptatt av å etterleve våre verdier som er: pålitelig, frisk, engasjert og nær. Vi bestreber at dette skal prege alle ansatte, alle beslutninger, alle handlinger og alle mål i selskapet. Apotek 1 Gruppen AS er eiet av den tyske Phoenix-gruppen. Servicekontor og distribusjonsenhet ligger på Lørenskog i Akershus. Vi er landets største leverandør av legemidler pakket i multidose, samt legemidler og tjenester til kommunehelsetjenesten, blant annet legemiddelgjennomganger.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Our mission is to create a thriving and evolving community of startups and creatives.DIGS is an innovation platform located in Trondheim, built on exchanges between members and partners who unite entrepreneurs, ‘makers’, and ‘doers’ from varied sectors. DIGS supports startup activities by providing an office environment and space for public activities, stimulating a culture of collaboration, sustainability, and mutual innovation through shared knowledge and experience. We participate in entrepreneurship networks across Norway, Europe, and internationally and aim to strengthen ties, stimulate the local community, and boost business development in and around the region of Trondheim. The idea of creating DIGS started with three enthusiastic people who wanted to make space for innovation in Trondheim. They started working on the idea in 2011 and acquired the space we are currently located in in the summer of 2013. The word DIGS means workplace and living space.

Skyfri Technologies AS is a global and fast-growing clean technology company based in Oslo, Calgary, Singapore and Hyderabad. Our advanced proprietary technology, powered by machine learning and big data, will completely digitize the way asset owners operate their power plants, and help them improve uptime and production. Our vision is to accelerate the deployment of renewable energy globally and we believe that software will be the engine to achieve that goal.

Subjekt er Norges raskest voksende kulturavis. Vi skal være landets ledende kulturavis og din beste venn i spørsmål om god smak. Vi publiserer nyheter, debattstoff, anmeldelser, featureartikler, kritikk og underholdning av og for en ung voksen, urban og kulturinteressert målgruppe. Dekningsområdet er kunst, kultur og samfunn i hele Norge. Ansvarlig redaktør er Danby Choi, som i 2020 ble nominert til Årets nyskaper av Oslo redaktørforening. Mer info: https://subjekt.no/om-subjekt